128 related articles for article (PubMed ID: 11858527)
1. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design.
Gohel MC; Panchal MK
Drug Dev Ind Pharm; 2002 Jan; 28(1):77-87. PubMed ID: 11858527
[TBL] [Abstract][Full Text] [Related]
2. Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation.
Gohel MC; Patel MM; Amin AF
Drug Dev Ind Pharm; 2003 May; 29(5):565-74. PubMed ID: 12779286
[TBL] [Abstract][Full Text] [Related]
3. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
Gohel MC; Amin AF; Patel KV; Panchal MK
Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
[TBL] [Abstract][Full Text] [Related]
4. Blend of guar gum and Eudragit shows excellent drug release retarding behavior in sustained release tablets.
Ahmad S; Jamshaid M; Mehmood R; Bashir I; Ali R; Jameel S
Pak J Pharm Sci; 2020 Jan; 33(1):71-77. PubMed ID: 32122833
[TBL] [Abstract][Full Text] [Related]
5. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
Kulkarni AS; Bhatia MS
PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
[TBL] [Abstract][Full Text] [Related]
6. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
Toti US; Aminabhavi TM
J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
[TBL] [Abstract][Full Text] [Related]
8. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
9. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
Varshosaz J; Tavakoli N; Kheirolahi F
AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Drug Release from Natural Polymer Matrices by Response Surface Methodology: in vitro and in vivo Evaluation.
Moin A; Gangadharappa HV; Adnan M; Rizvi SM; Ashraf SA; Patel M; Abu Lila AS; Allam AN
Drug Des Devel Ther; 2020; 14():5325-5336. PubMed ID: 33293794
[TBL] [Abstract][Full Text] [Related]
11. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
[TBL] [Abstract][Full Text] [Related]
12. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
13. Divisability of diltiazem matrix sustained-release tablets.
Costa P; Sousa Lobo JM
Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
[TBL] [Abstract][Full Text] [Related]
14. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
15. Guar gum-based sustained release diltiazem.
Altaf SA; Yu K; Parasrampuria J; Friend DR
Pharm Res; 1998 Aug; 15(8):1196-201. PubMed ID: 9706049
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
Khullar P; Khar RK; Agarwal SP
Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
[TBL] [Abstract][Full Text] [Related]
17. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
18. Influence of dissolution medium agitation on release profiles of sustained-release tablets.
Paulo ; Sousa Lobo JM
Drug Dev Ind Pharm; 2001 Sep; 27(8):811-7. PubMed ID: 11699832
[TBL] [Abstract][Full Text] [Related]
19. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.
Park CR; Munday DL
Drug Dev Ind Pharm; 2004 Jul; 30(6):609-17. PubMed ID: 15285334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
